MIA and Miyoshi myopathy: Moreover, the subcellular localization results reported that the final PS drug conjugate was more efficient at improved ZnPcS4 concentrated cellular absorption within the cytoplasm and nuclei of cells, due to its Anti-MIA Ab biomarker targeting affinity for MM cells.